Cargando…
Characterization of Monoclonal Antibody LpMab-3 Recognizing Sialylated Glycopeptide of Podoplanin
Podoplanin (PDPN/Aggrus/T1α/gp36/OTS-8), a type I transmembrane sialoglycoprotein, is involved in platelet aggregation, cell invasion, and cancer metastasis. Podoplanin expression in cancer cells or cancer-associated fibroblasts was reported to be involved in poor prognosis of several cancers. Furth...
Autores principales: | Oki, Hiroharu, Ogasawara, Satoshi, Kaneko, Mika Kato, Takagi, Michiaki, Yamauchi, Masanori, Kato, Yukinari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350263/ https://www.ncbi.nlm.nih.gov/pubmed/25723283 http://dx.doi.org/10.1089/mab.2014.0087 |
Ejemplares similares
-
LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-Glycan on Thr52 of Platelet Aggregation-Stimulating Domain of Human Podoplanin
por: Kato, Yukinari, et al.
Publicado: (2016) -
LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer
por: Miyazaki, Akihiro, et al.
Publicado: (2018) -
The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity
por: Kato, Yukinari, et al.
Publicado: (2015) -
A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
por: Kato, Yukinari, et al.
Publicado: (2014) -
Development and characterization of anti‐glycopeptide monoclonal antibodies against human podoplanin, using glycan‐deficient cell lines generated by CRISPR/Cas9 and TALEN
por: Kaneko, Mika K., et al.
Publicado: (2017)